IT1221077B - Anticorpi monoclonali di mammiferi contro endotossine di batteri gram negativi e loro impiego in terapia diagnosi e profilassi - Google Patents

Anticorpi monoclonali di mammiferi contro endotossine di batteri gram negativi e loro impiego in terapia diagnosi e profilassi

Info

Publication number
IT1221077B
IT1221077B IT68015/84A IT6801584A IT1221077B IT 1221077 B IT1221077 B IT 1221077B IT 68015/84 A IT68015/84 A IT 68015/84A IT 6801584 A IT6801584 A IT 6801584A IT 1221077 B IT1221077 B IT 1221077B
Authority
IT
Italy
Prior art keywords
prophylaxis
monoclonal antibodies
gram negative
mammals against
bacteria gram
Prior art date
Application number
IT68015/84A
Other languages
English (en)
Other versions
IT8468015A0 (it
Inventor
Jr Warren C Bogard
Patrick C Kung
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of IT8468015A0 publication Critical patent/IT8468015A0/it
Application granted granted Critical
Publication of IT1221077B publication Critical patent/IT1221077B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT68015/84A 1983-10-14 1984-10-15 Anticorpi monoclonali di mammiferi contro endotossine di batteri gram negativi e loro impiego in terapia diagnosi e profilassi IT1221077B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/542,111 US5179018A (en) 1983-10-14 1983-10-14 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria

Publications (2)

Publication Number Publication Date
IT8468015A0 IT8468015A0 (it) 1984-10-15
IT1221077B true IT1221077B (it) 1990-06-21

Family

ID=24162382

Family Applications (1)

Application Number Title Priority Date Filing Date
IT68015/84A IT1221077B (it) 1983-10-14 1984-10-15 Anticorpi monoclonali di mammiferi contro endotossine di batteri gram negativi e loro impiego in terapia diagnosi e profilassi

Country Status (15)

Country Link
US (1) US5179018A (it)
EP (2) EP0160670B1 (it)
JP (1) JPH0794479B2 (it)
AU (1) AU577554B2 (it)
DE (1) DE3486146T2 (it)
DK (1) DK270285A (it)
ES (1) ES8608170A1 (it)
FI (1) FI91711C (it)
GR (1) GR80621B (it)
IE (1) IE60643B1 (it)
IT (1) IT1221077B (it)
NO (1) NO852426L (it)
PT (1) PT79351B (it)
WO (1) WO1985001659A1 (it)
ZA (1) ZA847944B (it)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
FI853395L (fi) * 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
EP0183876A1 (en) * 1984-11-27 1986-06-11 The Board Of Trustees Of The Leland Stanford Junior University Monoclonal antibodies for endotoxin core and their use
EP0233289B1 (en) * 1984-12-26 1993-03-10 Teijin Limited Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody
ATE77243T1 (de) * 1985-03-11 1992-07-15 Teijin Ltd E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
FI870482A7 (fi) * 1985-06-06 1987-02-05 Genetic Systems Corp Suojaavat ihmisen monoklonaaliset vasta-aineet Pseudomonas aeruginosan eksotoksiini A:lle.
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
EP0494085A1 (en) 1985-09-27 1992-07-08 The Regents Of The University Of California Monoclonal antibodies binding determinants of gram negative bacteria
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DE3745019C2 (de) * 1986-02-07 1998-01-29 Genetic Systems Corp Kreuz-schützende monoklonale Humanantikörper
ZA87863B (en) * 1986-02-07 1987-09-30 Genetic Systems Corp Cross-protective human monoclonal antibody compositions
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
ES2009366A6 (es) * 1986-04-24 1989-09-16 Univ California Procedimiento de obtencion de anticuerpos monoclonales para bacterias gram-negativas.
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
FR2606421B1 (fr) * 1986-11-12 1990-01-26 Roussel Uclaf Anticorps monoclonaux antigram (-) procede de preparation et applications
EP0267615A3 (en) * 1986-11-13 1989-05-03 Sloan-Kettering Institute For Cancer Research Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2
ZA878610B (en) * 1986-11-20 1989-06-28 Minnesota Mining & Mfg Method for the evaluation of oral microbes
JPH0222295A (ja) * 1987-01-05 1990-01-25 Univ Pittsburgh ポリミキシンアガロースリポ多糖抗原及びこれに関連する方法
US4870158A (en) * 1987-01-05 1989-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Polymyxin lipopolysaccharide antigen and associated method
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
DE3843784A1 (de) * 1988-12-24 1990-06-28 Battelle Institut E V Verfahren zum nachweis von gramnegativen mikroorganismen sowie hierfuer geeignete dna-proben und antikoerper
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
US5449619A (en) * 1992-04-16 1995-09-12 Sybron Chemical Holdings, Inc. Drain opener formulation
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
US5496700A (en) * 1993-08-06 1996-03-05 The United States Of America As Represented By The Secretary Of The Navy Optical immunoassay for microbial analytes using non-specific dyes
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
JP2000503320A (ja) * 1996-01-16 2000-03-21 シブロン・ケミカル・ホールディングス・インコーポレーテッド 洗剤・殺菌剤調合剤
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US6790661B1 (en) * 1999-07-16 2004-09-14 Verax Biomedical, Inc. System for detecting bacteria in blood, blood products, and fluids of tissues
EP1575507A2 (en) * 2002-04-02 2005-09-21 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
AU2003901008A0 (en) * 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US20080114212A1 (en) 2006-10-10 2008-05-15 General Electric Company Detecting surgical phases and/or interventions
DE102005002969A1 (de) * 2005-01-21 2006-08-03 Profos Ag Verfahren zum Nachweis und zur Entfernung von Endotoxin
GB0621452D0 (en) 2006-10-27 2006-12-06 Ucl Business Plc Therapy for liver disease
US20130084586A1 (en) * 2011-09-30 2013-04-04 The Penn State Research Foundation Rapid, specific and sensitive immunoassays for the detection of highly variable gram negative bacterial antigens
EP2617833A1 (en) * 2012-01-18 2013-07-24 Centre National de la Recherche Scientifique (CNRS) A method for specifically detecting living bacteria
BR112019002039A2 (pt) 2016-08-05 2019-05-07 Medimmune, Llc anticorpos anti-o2 e uso dos mesmos
CA3039686A1 (en) 2016-10-19 2018-04-26 Medimmune, Llc Anti-o1 antibodies and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
FI853395L (fi) * 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria

Also Published As

Publication number Publication date
FI852380A0 (fi) 1985-06-14
PT79351B (en) 1986-09-08
EP0481970A2 (en) 1992-04-22
DE3486146T2 (de) 1993-12-09
AU3550284A (en) 1985-05-07
DE3486146D1 (de) 1993-06-17
ZA847944B (en) 1985-11-27
FI91711B (fi) 1994-04-29
ES8608170A1 (es) 1986-06-01
IE60643B1 (en) 1994-07-27
FI91711C (fi) 1994-08-10
NO852426L (no) 1985-06-14
ES536721A0 (es) 1986-06-01
GR80621B (en) 1985-02-18
IT8468015A0 (it) 1984-10-15
DK270285A (da) 1985-08-13
WO1985001659A1 (en) 1985-04-25
JPH0794479B2 (ja) 1995-10-11
IE842625L (en) 1985-04-24
PT79351A (en) 1984-11-01
US5179018A (en) 1993-01-12
DK270285D0 (da) 1985-06-14
JPS61500355A (ja) 1986-03-06
EP0160670B1 (en) 1993-05-12
AU577554B2 (en) 1988-09-29
EP0160670A1 (en) 1985-11-13
EP0481970A3 (en) 1992-09-30
FI852380L (fi) 1985-06-14

Similar Documents

Publication Publication Date Title
IT8468015A0 (it) Anticorpi monoclonali di mammiferi contro endotossine di batteri gramnegativi e loro impiego in terapia diagnosi e profilassi
IT8847858A0 (it) Agenti per la profilassi e la terapia di infezioni retrovirali
ES280303Y (es) Pano sanitario
FR2548830B1 (fr) Source d'ions negatifs
IL71017A0 (en) Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon
BE859851A (fr) Traitement d'infections bacteriennes
IT8220954A0 (it) Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle
MX161700A (es) Mejoras en procesador asociativo
FR2551617B1 (fr) Structure acceleratrice lineaire autofocalisante de particules chargees
IT8424031A0 (it) Struttura di tampone perl'isolamento di binari.
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
PT73283A (fr) Procede de preparation d'oxides de cephalosporines
IT1175692B (it) Trattamento di sintomi negativi di schizofrenia
IT1134476B (it) Dispositivo per migliorare la resistenza e la rigidita' di condotte sottomarine
FI830579A0 (fi) Med positiva pulser arbetande foerbearbetningsblad
IT1158004B (it) Apparecchio e procedimento per l'impilamento di articoli di forma appiattita particolarmente pannolini ed assorbenti
BR8405580A (pt) Linhagens de celulas hibridas que produzem anticorpos monoclonicos dirigidos contra o treponema e sua utilizacao no imuno-diagnostico das infeccoes por treponema
IT1163478B (it) Preparazione fermentativa di l.-leucina
IT1170403B (it) Carburatore sonico
TR22363A (tr) Alkillestirilmis antrakinonlarin aritilmasi
IT8467077A0 (it) Perfezionamenti ai rubinetti
IT1173937B (it) Trattamento delle infezioni erpetiche
ES491452A0 (es) Perfeccionamientos en la fabricacion de cintas transportado-ras
IT8349398A0 (it) Pepsina immobilizzata per l'impiego nella eliminazione di immunocomplessi dal sangue e procedimento per eliminare immunocomplessi dal sangue impiegando la pepsina immobilizzata
IT8349026A0 (it) Procedimento per la nobilitazione di formazioni di superfici tessili

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971031